487 related articles for article (PubMed ID: 29775216)
1. Neuroinflammation and microglia in glaucoma: time for a paradigm shift.
Wei X; Cho KS; Thee EF; Jager MJ; Chen DF
J Neurosci Res; 2019 Jan; 97(1):70-76. PubMed ID: 29775216
[TBL] [Abstract][Full Text] [Related]
2. Sub-region-Specific Optic Nerve Head Glial Activation in Glaucoma.
Oikawa K; Ver Hoeve JN; Teixeira LBC; Snyder KC; Kiland JA; Ellinwood NM; McLellan GJ
Mol Neurobiol; 2020 Jun; 57(6):2620-2638. PubMed ID: 32266645
[TBL] [Abstract][Full Text] [Related]
3. Transgenic inhibition of astroglial NF-κB restrains the neuroinflammatory and neurodegenerative outcomes of experimental mouse glaucoma.
Yang X; Zeng Q; Barış M; Tezel G
J Neuroinflammation; 2020 Aug; 17(1):252. PubMed ID: 32859212
[TBL] [Abstract][Full Text] [Related]
4. CNS axonal degeneration and transport deficits at the optic nerve head precede structural and functional loss of retinal ganglion cells in a mouse model of glaucoma.
Maddineni P; Kasetti RB; Patel PD; Millar JC; Kiehlbauch C; Clark AF; Zode GS
Mol Neurodegener; 2020 Aug; 15(1):48. PubMed ID: 32854767
[TBL] [Abstract][Full Text] [Related]
5. A small peptide antagonist of the Fas receptor inhibits neuroinflammation and prevents axon degeneration and retinal ganglion cell death in an inducible mouse model of glaucoma.
Krishnan A; Kocab AJ; Zacks DN; Marshak-Rothstein A; Gregory-Ksander M
J Neuroinflammation; 2019 Sep; 16(1):184. PubMed ID: 31570110
[TBL] [Abstract][Full Text] [Related]
6. Heterozygous Meg2 Ablation Causes Intraocular Pressure Elevation and Progressive Glaucomatous Neurodegeneration.
Reinhard J; Wiemann S; Joachim SC; Palmhof M; Woestmann J; Denecke B; Wang Y; Downey GP; Faissner A
Mol Neurobiol; 2019 Jun; 56(6):4322-4345. PubMed ID: 30315478
[TBL] [Abstract][Full Text] [Related]
7. IOP induces upregulation of GFAP and MHC-II and microglia reactivity in mice retina contralateral to experimental glaucoma.
Gallego BI; Salazar JJ; de Hoz R; Rojas B; Ramírez AI; Salinas-Navarro M; Ortín-Martínez A; Valiente-Soriano FJ; Avilés-Trigueros M; Villegas-Perez MP; Vidal-Sanz M; Triviño A; Ramírez JM
J Neuroinflammation; 2012 May; 9():92. PubMed ID: 22583833
[TBL] [Abstract][Full Text] [Related]
8. Etanercept, a widely used inhibitor of tumor necrosis factor-α (TNF-α), prevents retinal ganglion cell loss in a rat model of glaucoma.
Roh M; Zhang Y; Murakami Y; Thanos A; Lee SC; Vavvas DG; Benowitz LI; Miller JW
PLoS One; 2012; 7(7):e40065. PubMed ID: 22802951
[TBL] [Abstract][Full Text] [Related]
9. Under pressure: cellular and molecular responses during glaucoma, a common neurodegeneration with axonopathy.
Nickells RW; Howell GR; Soto I; John SW
Annu Rev Neurosci; 2012; 35():153-79. PubMed ID: 22524788
[TBL] [Abstract][Full Text] [Related]
10. Pathological high intraocular pressure induces glial cell reactive proliferation contributing to neuroinflammation of the blood-retinal barrier via the NOX2/ET-1 axis-controlled ERK1/2 pathway.
Shi X; Li P; Herb M; Liu H; Wang M; Wang X; Feng Y; van Beers T; Xia N; Li H; Prokosch V
J Neuroinflammation; 2024 Apr; 21(1):105. PubMed ID: 38649885
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-17A modulates retinal inflammation by regulating microglial activation via the p38 MAPK pathway in experimental glaucoma neuropathy.
Chen J; Zhong H; Yu H; Sun J; Shen B; Xu X; Huang S; Huang P; Zhong Y
FASEB J; 2023 Jun; 37(6):e22945. PubMed ID: 37144630
[TBL] [Abstract][Full Text] [Related]
12. Evidence Supporting an Association Between Expression of Major Histocompatibility Complex II by Microglia and Optic Nerve Degeneration During Experimental Glaucoma.
Chidlow G; Ebneter A; Wood JP; Casson RJ
J Glaucoma; 2016 Aug; 25(8):681-91. PubMed ID: 27253969
[TBL] [Abstract][Full Text] [Related]
13. Detection of early neuron degeneration and accompanying microglial responses in the retina of a rat model of glaucoma.
Naskar R; Wissing M; Thanos S
Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2962-8. PubMed ID: 12202516
[TBL] [Abstract][Full Text] [Related]
14. Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma.
Bosco A; Inman DM; Steele MR; Wu G; Soto I; Marsh-Armstrong N; Hubbard WC; Calkins DJ; Horner PJ; Vetter ML
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1437-46. PubMed ID: 18385061
[TBL] [Abstract][Full Text] [Related]
15. Time-dependent retinal ganglion cell loss, microglial activation and blood-retina-barrier tightness in an acute model of ocular hypertension.
Trost A; Motloch K; Bruckner D; Schroedl F; Bogner B; Kaser-Eichberger A; Runge C; Strohmaier C; Klein B; Aigner L; Reitsamer HA
Exp Eye Res; 2015 Jul; 136():59-71. PubMed ID: 26001526
[TBL] [Abstract][Full Text] [Related]
16. The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma.
Harada T; Harada C; Nakamura K; Quah HM; Okumura A; Namekata K; Saeki T; Aihara M; Yoshida H; Mitani A; Tanaka K
J Clin Invest; 2007 Jul; 117(7):1763-70. PubMed ID: 17607354
[TBL] [Abstract][Full Text] [Related]
17. Activation of Adenosine A
Ferreira-Silva J; Aires ID; Boia R; Ambrósio AF; Santiago AR
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33007835
[TBL] [Abstract][Full Text] [Related]
18. DRP1 inhibition rescues retinal ganglion cells and their axons by preserving mitochondrial integrity in a mouse model of glaucoma.
Kim KY; Perkins GA; Shim MS; Bushong E; Alcasid N; Ju S; Ellisman MH; Weinreb RN; Ju WK
Cell Death Dis; 2015 Aug; 6(8):e1839. PubMed ID: 26247724
[TBL] [Abstract][Full Text] [Related]
19. Neuroinflammation in Glaucoma and Optic Nerve Damage.
Mac Nair CE; Nickells RW
Prog Mol Biol Transl Sci; 2015; 134():343-63. PubMed ID: 26310164
[TBL] [Abstract][Full Text] [Related]
20. Expression and activation of mitogen-activated protein kinases in the optic nerve head in a rat model of ocular hypertension.
Mammone T; Chidlow G; Casson RJ; Wood JPM
Mol Cell Neurosci; 2018 Apr; 88():270-291. PubMed ID: 29408550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]